MedTrace Logo

Fish Oil for HIV-Related Inflamm-aging and Immune Senescence

NCT02102724 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2019-03-26

Study results available
· View outcomes & findings →

Summary

HIV infection is associated with premature aging of the immune system. It is believe that the persistent inflammation that accompanies HIV infection is a major contributor to premature immune aging. Fish oil has well-documented anti-inflammatory properties. In this randomized, clinical trial, we're testing whether a 12-week course of fish oil supplementation will reverse premature aging in HIV-infected older adults.

Conditions

  • HIV Infection

Interventions

DIETARY_SUPPLEMENT

Fish oil that contains omega-3 fatty acids

Fish oil gelcaps that contain 800 mg of EPA, 600 mg of DHA, 200 mg other omega-3 fatty acids

DIETARY_SUPPLEMENT

Placebo

Gelcaps that contain 1 gram of oleic sunflower oil

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Barbara A. Swanson, PhD, RN · Rush University College of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02102724 on ClinicalTrials.gov